Experienced in Spasmodic Dysphonia

Sandra U. Schmitz

Department Of Head & Neck Surgery, 
Brussels, BRU, BE 
Experienced in Spasmodic Dysphonia
Department Of Head & Neck Surgery, 
Brussels, BRU, BE 
OverviewLocationsClinical Research

Overview

Sandra Schmitz practices in Brussels, Belgium. Ms. Schmitz is rated as an Experienced expert by MediFind in the treatment of Spasmodic Dysphonia. Her top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Necrotizing Granuloma, Klippel-Trenaunay Syndrome, Gastrostomy, and Laryngectomy.

Her clinical research consists of co-authoring 77 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Spasmodic Dysphonia.

Gender
Female

Locations

Department Of Head & Neck Surgery, Brussels, BRU, Belgium
Other Locations
Leuven, VLG, Belgium
Departments Of Medical Oncology And Head And Neck Surgery, Saint-lambert, WAL, Belgium
Belgium
Rue De Liroux, 4, Gembloux, WAL 5030, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Phase III Study Assessing the Best of Radiotherapy Compared to the Best of Surgery (Trans-oral Surgery (TOS)) in Patients With T1-T2, N0-N1 Oropharyngeal, Supraglottic Carcinoma and With T1, N0 Hypopharyngeal Carcinoma
Phase III Study Assessing the Best of Radiotherapy Compared to the Best of Surgery (Trans-oral Surgery (TOS)) in Patients With T1-T2, N0-N1 Oropharyngeal, Supraglottic Carcinoma and With T1, N0 Hypopharyngeal Carcinoma
Enrollment Status: Active_not_recruiting
Publish Date: August 14, 2025
Intervention Type: Radiation, Procedure
Study Phase: Not Applicable

77 Total Publications

Translational investigations in the HN1901 phase II window-of-opportunity study investigating the biological activity of an IDO1 (IO102) and PD-L1 (IO103) immune-modulatory peptide cancer vaccines in squamous cell carcinoma of the head and neck.
Translational investigations in the HN1901 phase II window-of-opportunity study investigating the biological activity of an IDO1 (IO102) and PD-L1 (IO103) immune-modulatory peptide cancer vaccines in squamous cell carcinoma of the head and neck.
Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
Published: April 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Schmitz's expertise for a condition
ConditionClose
    View All 15 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile